VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...

Tokyo-based investment giant Softbank wants to combine cells created from humans, which mimic brain cells, with traditional technology in an effort to create ...

The groundbreaking partnership focuses on leveraging AI to unlock advancements in cellular regeneration and anti-ageing ...

A new national survey found that while many Americans use a device to monitor their heart, few share that data with their doctor.